Pre-clinical studies using cell culture (in vitro) and laboratory animal (in vivo) models are carried out to obtain safety data and pharmacological profiles of the antibodies prior to conducting clinical trials in cancer patients. This pre-clinical drug development program is being developed by RECEPTA biopharma company in collaboration with several partnerships in Brazil and abroad.